Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reveal strong support for the study's approach to building effective collective intelligence networks, with phrases like 'key for improving patient care' and 'promising method for policy integration' demonstrating a positive tone and perceived significance. The tone remains professional yet optimistic, emphasizing the potential benefits for multiple stakeholders involved in rare disease management.
Most discussions support the importance of the study, highlighting its relevance for stakeholders involved in rare disease networks.
The discussions reflect high interest due to emphasis on collaborative approaches and potential improvements in policy and patient outcomes.
Comments mainly involve recognition and brief analysis, indicating moderate but genuine engagement with the subject.
Participants suggest that this research could influence policy and enhance network coordination, pointing to a notable, though not transformational, impact.
Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus https://t.co/YZkrB7BlYe
“Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus” at https://t.co/Fp5BLNU9vU
This video explores a mixed method approach to developing effective collective intelligence networks for rare diseases, focusing on key parameters valued by patients, professionals, and policymakers, based on a pilot…
“Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus” at https://t.co/Fp5BLNU9vU
Co-constructing effective collective intelligence networks in rare diseases: a mixed method approach to identify the parameters that matter for patients, professionals and policy-makers, piloted in Cyprus https://t.co/YZkrB7BlYe
DR
RC